Apollomics to present at the h.c. wainwright 26th annual global investment conference

Foster city, calif., sept. 04, 2024 (globe newswire) -- apollomics inc. (nasdaq: aplm) (“apollomics” or the “company”), a late-stage clinical biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers, today announced company management will be presenting at the h.c. wainwright 26th annual global investment conference taking place on september 9-11, 2024 virtually and in person at the lotte new york palace hotel in new york, ny.
APLM Ratings Summary
APLM Quant Ranking